Organism name | Consolida axilliflora DC Schrod |
---|---|
Genus | Consolida |
Family | Ranunculaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Consolida |
---|---|
Linked NCBI taxonomy ID | 37493 |
Linked level | genus |
Family in NCBI taxonomy | Ranunculaceae |
---|---|
ID | 3440 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | eudicotyledons |
---|---|
ID | 71240 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00001653
![]() |
Lycoctonine
/ (+)-Lycoctonine |
CHEMBL517003
CHEMBL1242718 CHEMBL1303310 CHEMBL1975737 CHEMBL2356607 |
C093992
|
3 / 10 / 7 | No. 31 | No. 10 |
![]() |
|
C00028157
![]() |
Delectinine
|
CHEMBL1242719
|
No. 31 | No. 10 |
![]() |
|||
C00029071
![]() |
Takaosamine
|
No. 31 | No. 10 |
![]() |
||||
C00028344
![]() |
Hetisine
/ Delatine |
CHEMBL1315226
|
1 / 0 / 0 | No. 121 | No. 10 |
![]() |
||
C00028578
![]() |
Methyllycaconitine
|
CHEMBL223494
CHEMBL387362 CHEMBL510275 CHEMBL1412391 CHEMBL1592980 CHEMBL1620703 CHEMBL1869403 CHEMBL2094019 |
C054634
|
21 / 12 / 8 | 15 / 7 | No. 166 | No. 10 |
![]() |
C00027824
![]() |
Ajaconine
|
No. 274 | No. 10 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00028578 | 1 / 0 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00028578 | 2 / 0 |
P23415 | Glycine receptor subunit alpha-1 | GLR alpha | C00028578 | 1 / 1 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00028578 | 0 / 1 |
P30926 | Neuronal acetylcholine receptor subunit beta-4 | CHRN beta | C00028578 | 0 / 0 |
P32297 | Neuronal acetylcholine receptor subunit alpha-3 | CHRN alpha | C00028578 | 1 / 0 |
P43681 | Neuronal acetylcholine receptor subunit alpha-4 | CHRN alpha | C00028578 | 1 / 1 |
P17787 | Neuronal acetylcholine receptor subunit beta-2 | CHRN beta | C00028578 | 1 / 1 |
P11473 | Vitamin D3 receptor | NR1I1 | C00001653 | 2 / 3 |
P46098 | 5-hydroxytryptamine receptor 3A | NS | C00028578 | 0 / 0 |
P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00001653 | 7 / 3 |
P36544 | Neuronal acetylcholine receptor subunit alpha-7 | CHRN alpha | C00028578 | 0 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00028578 | 0 / 0 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00028578 | 3 / 3 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00028578 | 1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00028578 | 0 / 1 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00028344 | 0 / 0 |
Q15822 | Neuronal acetylcholine receptor subunit alpha-2 | CHRN alpha | C00028578 | 1 / 1 |
Q8WXA8 | 5-hydroxytryptamine receptor 3C | NS | C00028578 | 0 / 0 |
Q70Z44 | 5-hydroxytryptamine receptor 3D | NS | C00028578 | 0 / 0 |
O95264 | 5-hydroxytryptamine receptor 3B | NS | C00028578 | 0 / 0 |
A5X5Y0 | 5-hydroxytryptamine receptor 3E | NS | C00028578 | 0 / 0 |
Q9UGM1 | Neuronal acetylcholine receptor subunit alpha-9 | CHRN alpha | C00028578 | 0 / 0 |
Q9GZZ6 | Neuronal acetylcholine receptor subunit alpha-10 | CHRN alpha | C00028578 | 0 / 0 |
Q13148 | TAR DNA-binding protein 43 | Unclassified protein | C00001653 | 1 / 1 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00028578
|
627 | BDNF, ANON2, BULN2 | brain-derived neurotrophic factor |
C00028578
|
1137 | CHRNA4, BFNC, EBN, EBN1, NACHR, NACHRA4, NACRA4 | cholinergic receptor, nicotinic, alpha 4 (neuronal) |
C00028578
|
1139 | CHRNA7, CHRNA7-2, NACHRA7 | cholinergic receptor, nicotinic, alpha 7 (neuronal) |
C00028578
|
1141 | CHRNB2, EFNL3, nAChRB2 | cholinergic receptor, nicotinic, beta 2 (neuronal) |
C00028578
|
1621 | DBH, DBM | dopamine beta-hydroxylase (dopamine beta-monooxygenase) (EC:1.14.17.1) |
C00028578
|
3674 | ITGA2B, BDPLT16, BDPLT2, CD41, CD41B, GP2B, GPIIb, GT, GTA, HPA3 | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) |
C00028578
|
3690 | ITGB3, BDPLT16, BDPLT2, CD61, GP3A, GPIIIa, GT | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) |
C00028578
|
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00028578
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00028578
|
4915 | NTRK2, GP145-TrkB, TRKB, trk-B | neurotrophic tyrosine kinase, receptor, type 2 (EC:2.7.10.1) |
C00028578
|
6774 | STAT3, APRF, HIES | signal transducer and activator of transcription 3 (acute-phase response factor) |
C00028578
|
7054 | TH, DYT14, DYT5b, TYH | tyrosine hydroxylase (EC:1.14.16.2) |
C00028578
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00028578
|
7538 | ZFP36, G0S24, GOS24, NUP475, RNF162A, TIS11, TTP, zfp-36 | ZFP36 ring finger protein |
C00028578
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
#612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 |
Q13148
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#600513 | Epilepsy, nocturnal frontal lobe, 1; enfl1 |
P43681
|
#605375 | Epilepsy, nocturnal frontal lobe, 3; enfl3 |
P17787
|
#610353 | Epilepsy, nocturnal frontal lobe, 4; enfl4 |
Q15822
|
#149400 | Hyperekplexia, hereditary 1; hkpx1 |
P23415
|
#174800 | Mccune-albright syndrome; mas |
P63092
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#166350 | Osseous heteroplasia, progressive; poh |
P63092
|
#102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
#103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
#603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
#612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#612052 | Smoking as a quantitative trait locus 3; sqtl3 |
P32297
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
KEGG | name | UniProt |
---|---|---|
H00036 | Osteosarcoma |
P08684
(marker)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00807 | Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) |
P17787
(related)
P43681 (related) Q15822 (related) |
H00769 | Hyperekplexia |
P23415
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
Q13148
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
Q99714
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|